BIOVENTUS INC. - CLASS A COMMON STOCK
6.8000
08-May-25 16:45:00
15 minutes delayed
Stocks
+0.2100
+3.19%
Today's range
6.5000 - 7.0650
ISIN
N/A
Source
NASDAQ
-
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
21 Nov 2022 17:15:01 By Nasdaq GlobeNewswire
-
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022
16 Nov 2022 17:15:00 By Nasdaq GlobeNewswire
-
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
08 Nov 2022 07:30:01 By Nasdaq GlobeNewswire
-
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
31 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Bioventus to Present at the Morgan Stanley Global Healthcare Conference
30 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
11 Aug 2022 07:00:03 By Nasdaq GlobeNewswire
-
Bioventus Receives FDA 510(k) Clearance for SonaStar Elite
03 Aug 2022 07:00:02 By Nasdaq GlobeNewswire
-
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
26 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Bioventus Completes CartiHeal Acquisition
12 Jul 2022 08:30:00 By Nasdaq GlobeNewswire
-
Bioventus Amends CartiHeal Acquisition Structure
21 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
10 May 2022 07:00:04 By Nasdaq GlobeNewswire
-
03 May 2022 17:47:17 By Nasdaq GlobeNewswire
-
02 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
26 Apr 2022 09:05:09 By Nasdaq GlobeNewswire
-
Bioventus Announces $415 Million Offering of Senior Notes
26 Apr 2022 08:38:49 By Nasdaq GlobeNewswire
-
Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
25 Apr 2022 07:00:01 By Nasdaq GlobeNewswire
-
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
08 Apr 2022 09:15:08 By Nasdaq GlobeNewswire
-
Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton
05 Apr 2022 07:00:01 By Nasdaq GlobeNewswire
-
Bioventus Exercises Call Option to Acquire CartiHeal
04 Apr 2022 07:00:00 By Nasdaq GlobeNewswire